Epidemiological features and clinical variants of inflammatory bowel diseases in St. Petersburg in the setting of outpatient practice

Abstract

Epidemiological features and clinical variants of inflammatory bowel diseases in St. Petersburg in conditions of outpatient practice are considered. It was established that among patients suffering from ulcerative colitis in the Vyborg and Frunze regions, women predominate in a ratio of 1:2. At the same time, more than 50% of cases of ulcerative colitis and Crohn’s disease come from the age of 20–49 years. The vast majority of patients examined with ulcerative colitis experienced a moderate attack. In more than half of cases, left-sided localization was noted with endoscopic activity of 2–3 points on the Schroeder scale, rectal lesion was observed in 22% of cases, total colitis was detected in only 14%. In general, the incidence and prevalence of ulcerative colitis in the Vyborg and Frunze regions is higher than Crohn’s disease. However, more extensive and lengthy studies of the problem are needed, but there are some difficulties associated with the lack of a unified registration base for patients suffering from inflammatory bowel diseases. Given that the incidence of ulcerative colitis and Crohn’s disease is higher among women and more than 50% of patients are of the most able-bodied age (20–49 years), inflammatory bowel disease is a group of highly relevant and socially significant diseases. Lower figures for the incidence and prevalence of inflammatory bowel diseases compared with those of developed countries indicate insufficient detection, diagnostic and clinical features of these diseases, as well as the need to optimize specialized medical care in places of residence of patients suffering from inflammatory bowel diseases. Nevertheless, currently in St. Petersburg and the Leningrad Region a fairly effective system of early detection and dynamic observation of patients suffering from ulcerative colitis has been created, which includes the activities of therapists and gastroenterologists of polyclinics, endoscopists and specialists of centers for the treatment of inflammatory bowel diseases of academic and university clinics.

Keywords

inflammatory bowel diseases / ulcerative colitis / Crohn’s disease / total colitis / epidemiological features / dynamic observation / early detection system / socially significant diseases

References

[1] Абдулхаков, С.Р. Неспецифический язвенный колит: современные подходы к диагностике и лечению / С.Р. Абдулхаков, Р.А. Абдулхаков // Вестн. совр. клин. мед. – 2009. – Т. 2, №. 1. – С. 32–41.

[2] Бакулин, И.Г. Опыт внедрения федерального регистра пациентов с воспалительными заболеваниями кишечника в Санкт-Петербурге / И.Г. Бакулин [и др.] // Фарматека. – 2017. – S 5. – С. 56.

[3] Златкина, А.Р. Эпидемиологические аспекты воспалительных заболеваний кишечника в Московской области / А.Р. Златкина, Е.А. Белоусова, И.В. Никулина // Альманах клин. мед. – 1999. – № 2. – С. 41–50.

[4] Ивашкин, В.Т. Рекомендации Российской гастроэнтерологической ассоциации и ассоциации колопроктологов России по диагностике и лечению взрослых больных язвенным колитом / В.Т. Ивашкин [и др.] // Росс. журн. гастроэнт., гепатолог., колопр. – 2015. – № 1. – С. 48–65.

[5] Маев, И.В. Патоморфоз воспалительных заболеваний кишечника / И.В. Маев [и др.] // Вестн. РАМН. – 2020. – Т. 75, № 1. – С. 27–35.

[6] Низов, А.А. Эпидемиологическая характеристика воспалительных заболеваний кишечника и реальная клиническая практика ведения больных в Рязанской области / А.А. Низов, А.Г. Якубовская // Вестн. Сев.-Зап. гос. мед. ун. им. И.И. Мечникова. – 2013. – Т. 5, № 1. – С. 88–92.

[7] Осипенко, М.Ф. Регистр воспалительных заболеваний кишечника в г. Новосибирске: итоги – 2016 / М.Ф. Осипенко [и др.] // Сиб. научн. мед. журн. – 2017. – Т. 37, № 1. – С. 61–67.

[8] Плахотников, И.А. Патогенетические механизмы формирования осложненных и резистентных форм язвенного колита и методы их коррекции: автореф. дис. … д-ра мед. наук / И.А. Плахотников. – Донецк, 2020. – 40 с.

[9] Харитонов, А.Г. Клинико-генетические и иммунологические характеристики различных вариантов течения язвенного колита: автореф. дис. … канд. мед. наук / А.Г. Харитонов. – СПб., 2013. – 22 с.

[10] Ananthakrishnan, A.N. Treatment of Ulcerative Colitis in the Elderly / A.N. Ananthakrishnan, D.G. Binion // Dig Dis. – 2009. – № 27. – Р. 327–334.

[11] Arnott, I. The Management of Inflammatory Bowel Disease in Elderly: Current Evidence and Future Perspectives / I. Arnott, G. Rogler, J. Halfvarson // Inflamm Intest Dis. – 2018. – Vol. 2, № 4. – P. 189–199.

[12] Bhatia, R. Inflammatory bowel disease incidence, prevalence and 12-month initial disease course in Tasmania, Australia / R. Bhatia [et al.] // Intern Med. J. – 2019. – Vol. 49, № 5. – P. 622–630.

[13] Brunet, E. Prevalence, incidence and mortality of inflammatory bowel disease in Catalonia. A population-based analysis / E. Brunet [et al.] // Annals of Medicine. – 2018. – Vol. 50, № 7. – P. 613–619.

[14] Burisc, J. The burden of inflammatory bowel disease in Europe / J. Burisch [et al.] // Journal of Crohn’s and Colitis. – 2013. – Vol. 7, № 4. – P. 322–337.

[15] Cosnes, J. Epidemiology and natural history of inflammatory bowel diseases / J. Cosnes [et al.] // Gastroenterology. – 2011. – Vol. 140, № 6. – P. 1785–1794.

[16] Cui, G. A Systematic Review of Epidemiology and Risk Factors Associated With Chinese Inflammatory Bowel Disease / G. Cui [et al.] // Front Med. (Lausanne). – 2018. – Vol. 19, № 5. –P. 183.

[17] Harbord, М. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management / M. Harbord [et al.] // Journal of Crohn’s and Colitis. – 2017. – P. 769–784.

[18] Misra, R. Epidemiology of inflammatory bowel disease in racial and ethnic migrant groups / R. Misra [et al.] // World J. Gastroenterol. – 2018. – Vol. 24, № 3. – Р. 424–437.

[19] Molodecky, N.A. Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review / N.A. Molodecky [et al.] // Gastroenterology. – 2012. – Vol. 142, № 1. – P. 46–54.

[20] Ng, S.C. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies / S.C. Ng [et al.] // Lancet. – 2018. – Vol. 390, Issue 10114. – P. 2769–2778.

[21] Prideaux, L. Inflammatory bowel disease in Asia: A systematic review / L. Prideaux [et al.] // Journal of Gastroenterology and Hepatology. – 2012. –№ 27. – P. 1266–1280.

[22] Severs, M. Sex-Related Differences in Patients With Inflammatory Bowel Disease: Results of 2 Prospective Cohort Studies / M. Severs [et al.] // Inflamm Bowel Dis. – 2018. – Vol. 24, № 6. – Р. 1298–1306.

[23] Shailja, S.C. Sex-Based Differences in Incidence of Inflammatory Bowel Diseases – Pooled Analysis of Population-Based Studies From Western Countries / S.C. Shailja [et al.] // Gastroenterology. – 2018. – Vol. 155, № 4. – Р. 1079–1089.

[24] Sturm, А. European Crohn’s and Colitis Organisation Topical Review on IBD in the Elderly / A. Sturm [ et al.] // Journal of Crohn’s and Colitis. –2017. – Vol. 11, № 3. – P. 263–273.

[25] Yamamoto-Furusho, J.K. Incidence and prevalence of inflammatory bowel disease in Mexico from a nationwide cohort study in a period of 15 years (2000–2017) / J.K. Yamamoto-Furusho [et al.] // Medicine (Baltimore). – 2019. – Vol. 98, № 27. – e.16291.

[26] Ye, L. Review of Inflammatory Bowel Disease in China / L. Ye [et al.] // The Scientific World Journal. – 2013. – Vol. 2013. – 6 р.

RIGHTS & PERMISSIONS

Purgina D.S., Solovyev M.V., Lyalina L.V., Rassokhin V.V.